PT-141 10mg

$99.00

Premium Research Peptide

OZPeptides PT-141 10mg is a premium research-grade peptide manufactured to rigorous quality standards for laboratory and scientific research applications. Every batch is produced with a focus on purity, consistency, and reliability, providing researchers with a dependable peptide for analytical and laboratory testing.

PT-141 (also known as Bremelanotide) is supplied as a lyophilised (freeze-dried) powder in a sterile, tamper-evident glass vial to help maintain product stability during storage and handling. PT-141 is commonly investigated in laboratory research involving melanocortin receptor activity and neuroendocrine signalling.

Product Features

  • 10mg PT-141 per vial

  • High-purity research-grade peptide

  • Lyophilised powder for enhanced stability

  • Sterile, tamper-evident glass vial

  • Batch tested for quality and consistency

  • Secure protective packaging

  • Fast shipping throughout Australia and New Zealand

Storage

Store refrigerated between 2°C and 8°C. Protect from direct sunlight, excessive heat, and moisture. Once reconstituted, store in accordance with appropriate laboratory storage protocols.

Package Contents

  • 1 × PT-141 10mg research vial

  • Protective packaging for secure transport

Research Areas

PT-141 (Bremelanotide) is a synthetic peptide that has been investigated for its activity at melanocortin receptors and its effects on neuroendocrine signalling. Research continues to explore its biological mechanisms and receptor interactions in laboratory and clinical settings.

Current areas of scientific investigation include:

  • Melanocortin receptor biology

  • MC3R and MC4R receptor signalling pathways

  • Neuroendocrine signalling mechanisms

  • Central nervous system peptide signalling

  • Neurotransmitter regulation and neuronal communication

  • Pharmacokinetic and pharmacodynamic profiling

  • Peptide–receptor interaction studies

  • Endocrine physiology research

  • Behavioural neuroscience models

  • Autonomic nervous system research

  • Cellular signalling pathways

  • Experimental peptide pharmacology

  • Receptor selectivity and activation studies

  • Structure–activity relationship (SAR) investigations

  • Experimental peptide therapeutic research

Research Use Only

PT-141 is supplied exclusively for laboratory and scientific research purposes only

Premium Research Peptide

OZPeptides PT-141 10mg is a premium research-grade peptide manufactured to rigorous quality standards for laboratory and scientific research applications. Every batch is produced with a focus on purity, consistency, and reliability, providing researchers with a dependable peptide for analytical and laboratory testing.

PT-141 (also known as Bremelanotide) is supplied as a lyophilised (freeze-dried) powder in a sterile, tamper-evident glass vial to help maintain product stability during storage and handling. PT-141 is commonly investigated in laboratory research involving melanocortin receptor activity and neuroendocrine signalling.

Product Features

  • 10mg PT-141 per vial

  • High-purity research-grade peptide

  • Lyophilised powder for enhanced stability

  • Sterile, tamper-evident glass vial

  • Batch tested for quality and consistency

  • Secure protective packaging

  • Fast shipping throughout Australia and New Zealand

Storage

Store refrigerated between 2°C and 8°C. Protect from direct sunlight, excessive heat, and moisture. Once reconstituted, store in accordance with appropriate laboratory storage protocols.

Package Contents

  • 1 × PT-141 10mg research vial

  • Protective packaging for secure transport

Research Areas

PT-141 (Bremelanotide) is a synthetic peptide that has been investigated for its activity at melanocortin receptors and its effects on neuroendocrine signalling. Research continues to explore its biological mechanisms and receptor interactions in laboratory and clinical settings.

Current areas of scientific investigation include:

  • Melanocortin receptor biology

  • MC3R and MC4R receptor signalling pathways

  • Neuroendocrine signalling mechanisms

  • Central nervous system peptide signalling

  • Neurotransmitter regulation and neuronal communication

  • Pharmacokinetic and pharmacodynamic profiling

  • Peptide–receptor interaction studies

  • Endocrine physiology research

  • Behavioural neuroscience models

  • Autonomic nervous system research

  • Cellular signalling pathways

  • Experimental peptide pharmacology

  • Receptor selectivity and activation studies

  • Structure–activity relationship (SAR) investigations

  • Experimental peptide therapeutic research

Research Use Only

PT-141 is supplied exclusively for laboratory and scientific research purposes only